/Companies

Rocket Pharma

Founded 2015 · Incorporated in Cayman Islands · 223 employees on LinkedIn · 6 known investors

Find your way into Rocket Pharma

Sign up to see every warm intro you have to Rocket Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Rocket Pharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders. The company creates potentially curative treatments at the genetic level for inherited and rare diseases.

Founders & leadership

Rocket Pharma was founded in 2015 by Gaurav Shah.

GSGaurav Shah
Gaurav ShahCo-founder & Chief Executive OfficerGaurav Shah trained as a medical oncologist and neuro-oncologist at Harvard and Memorial Sloan-Kettering; he previously held roles at Novartis including Global Program Head for the CART-19 cell and gene therapy unit, where he led pivotal trials in CAR-T therapies for hematologic malignancies, and earlier served as Medical Director at ImClone/Eli Lilly overseeing oncology trials.

Board

RW
Roderick WongBoard directorManaging Partner, CIO at RTW Investments L.P.
NYNaveen Yalamanchi
Naveen YalamanchiCo-Founder and Board Director2015–2025Partner, Portfolio Manager at RTW Investments L.P.

Investors · 6

Reported raises · per SEC filings

Form D private placements

$41.6M disclosed across 2 rounds · 2015–2017

▶$25.1MraisedMay 2017 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Naveen YalamanchiDirector
  • Gaurav ShahExecutive Officer
  • Roderick WongDirector
Offering amount
$30.1M
Amount sold
$25.1M
Minimum investment
$24K
First sale
Feb 2017
Incorporated
Other, Cayman Islands, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.4MraisedJan 2016 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roderick WongDirector
  • Gaurav ShahExecutive Officer
  • Naveen YalamanchiDirector
Offering amount
$38M
Amount sold
$16.4M
Minimum investment
$75K
First sale
Dec 2015
Incorporated
Other, Cayman Islands, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Rocket Pharma.

Frequently asked questions

What does Rocket Pharma do?
Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders. The company creates potentially curative treatments at the genetic level for inherited and rare diseases.
Who founded Rocket Pharma?
Rocket Pharma was founded by Gaurav Shah in 2015.
Who are Rocket Pharma's investors?
Rocket Pharma's investors include Avoro Capital Advisors, Broadview Ventures, Civilization Ventures Management, Llc, Frazier Life Sciences, LifeSci Venture Partners, RTW Investments L.P..
How much funding has Rocket Pharma raised?
Rocket Pharma has disclosed $41.6M raised across 2 rounds.